About this trial
This prospective, multicenter observational registry systematically captures all emergency department tracheal intubations across participating hospitals in Taiwan. The registry focuses on process quality indicators, including first-pass success, and patient-safety outcomes, including hypoxemia, hypotension, and peri-intubation cardiac arrest within 30 minutes of intubation. Routinely generated laboratory and physiologic variables are also collected to improve risk stratification and identify predictors of major adverse events. The study is non-interventional and does not alter clinical care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing tracheal intubation in the emergency department during the study period
Disqualifiers
Prehospital intubation; intubation performed solely for elective anesthesia/procedural sedation outside emergency indications
Trial population
Consecutive adult emergency department patients undergoing tracheal intubation at participating hospitals in Taiwan.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of major adverse peri-intubation events within 30 minutes after the start of intubation
severe hypoxemia, severe hypotension/cardiovascular instability, or cardiac arrest.
Secondary outcomes
First-pass success
In-hospital mortality
Other outcomes
Pre-intubation severe metabolic acidosis
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: